TD Cowen initiated coverage on CG Oncology
$CGON
TD Cowen initiated coverage of CG Oncology with a rating of Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/2/2025 | $41.00 | Overweight | Analyst |
| 4/16/2025 | $23.00 | Sector Perform | Scotiabank |
| 1/7/2025 | Buy | TD Cowen | |
| 10/24/2024 | $60.00 | Buy | UBS |
| 9/23/2024 | $66.00 | Outperform | RBC Capital Mkts |
| 8/28/2024 | $65.00 | Buy | ROTH MKM |
| 6/28/2024 | $65.00 | Buy | BofA Securities |
| 2/20/2024 | $75.00 | Overweight | Cantor Fitzgerald |